Clinical Trials Logo

Shock clinical trials

View clinical trials related to Shock.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT06217562 Enrolling by invitation - Septic Shock Clinical Trials

Vasopressin for Septic Shock Pragmatic Trial

VASSPR
Start date: February 1, 2024
Phase: Phase 4
Study type: Interventional

Life-threatening low blood pressure due to a serious infection is called "septic shock." Septic shock is treated with vasopressors, medications that raise blood pressure. Sometimes first-line vasopressors are inadequate, prompting addition of a second-line vasopressor called vasopressin. However, the threshold at which to start vasopressin remains unclear. This pragmatic, cluster-randomized, cluster-crossover trial will evaluate two different strategies for septic shock treatment commonly used in current practice, comparing a lower versus a higher threshold for adding vasopressin to first-line vasopressors.

NCT ID: NCT05800951 Enrolling by invitation - Clinical trials for Acute Myocardial Infarction

Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock

CERAMICS
Start date: July 22, 2022
Phase:
Study type: Observational [Patient Registry]

The CERAMICS study is designed to more clearly delineate the current care of acute myocardial infarction with cardiogenic shock (AMICS) patients who are treated with mechanical circulatory support (MCS) devices in the United States with significant experience in MCS, all of whom have the capability of MCS escalation on-site. Study enrollment is targeted at 120 patients at 20 hospital sites, evaluating clinical outcomes, and focusing on outcomes MCS escalation decision making and ICU level management.

NCT ID: NCT05570864 Enrolling by invitation - Clinical trials for Acute Coronary Syndrome

Score TO Predict SHOCK - STOP SHOCK

Start date: October 2022
Phase:
Study type: Observational [Patient Registry]

The goal of this international multicenter study is to develop a scoring system to identify the risk of developing cardiogenic shock (CS) in patients suffering from acute coronary syndrome (ACS) utilising artificial intelligence. Study hypothesis: A complex machine learning (ML) model utilising standard patient's admission data predicts the development of cardiogenic shock in patients suffering from acute myocardial infarction better than standard prediction models. Study objectives: The primary objective of this study is to further improve predictive parameters of #STOPSHOCK model for prediction of development of cardiogenic shock in patients suffering from acute myocardial infarction. The secondary objective of this study is to develop a new predictive model for the development of cardiogenic shock in patients suffering from acute myocardial infarction based on larger combined cohort of patients utilising advanced ML algorithms, continuous model performance monitoring and continual learning.

NCT ID: NCT05073354 Enrolling by invitation - Shock Clinical Trials

Rapid Treatment of Shock Without Trauma

SWOT
Start date: June 29, 2021
Phase:
Study type: Observational

Evaluate the implementation of a standardized mobile resuscitation model to manage SWOT within a large acute care hospital setting.

NCT ID: NCT03155126 Enrolling by invitation - Shock Clinical Trials

Different Crystalloids on AKI in Shock

Start date: June 2017
Phase: N/A
Study type: Observational

The goal is to observe that the incidence of acute kidney injury in patients who need fluid resuscitation when resuscitated with saline or acetated Ringer's sodium.

NCT ID: NCT02982876 Enrolling by invitation - Clinical trials for Tracheobronchomalacia

Airway Stents for Excessive Dynamic Airway Collapse

Start date: December 2016
Phase: N/A
Study type: Interventional

Airway stents are used as standard of care to identify which patients with excessive dynamic airway collapse will benefit from a definitive surgical treatment. However, the specific way in which these stents are effective has not been tested. The purpose of this research study is to determine the effectiveness of airway stents when used in the airways of patients with severe symptomatic excessive dynamic airway collapse compared to patients with severe symptomatic excessive dynamic airway collapse that do not receive airway stent.

NCT ID: NCT00914563 Enrolling by invitation - Burns Clinical Trials

An Upgrading of the Resuscitative Patterns by Utilization of the Balanced Crystalloids and Synthetic Colloids and the Non-Invasive Hemodynamic Monitoring During Burn Shock

FACT in BURNS
Start date: June 2009
Phase: Phase 2
Study type: Interventional

Fluid Therapy Lithium Dilution Cardiac Output (LIDCO) controlled trial in BURNS (FACT in BURNS) is a prospective randomized multicentric study. Introduction: The goal of this trial is the verification, optional upgrading and optimizing of the resuscitative patterns in light of the new generation of balanced crystalloids and colloids and, by utilization the non-invasive hemodynamic monitoring LIDCO.

NCT ID: NCT00837525 Enrolling by invitation - Clinical trials for Nasal Valve Collapse

Validity Study of a Nasal Valve Implant

Start date: February 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if an implant material can be injected to repair nasal valve collapse.